Galectin Therapeutics Inc (GALT)

1.03 -0.97 (-48.50%) USD  |  NASDAQ  |  Dec 20, 16:00
1.00 -0.03 (-2.91%) After-Hours: 20:00
More

Galectin Therapeutics EV to Revenues

EV to Revenues Chart

View EV to Revenues for GALT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EV to Revenues Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EV to Revenues Range, Past 5 Years

View EV to Revenues Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EV to Revenues Benchmarks

View EV to Revenues Benchmarks
Start Trial
Alaunos Therapeutics Inc --
SELLAS Life Sciences Group Inc --
Oragenics Inc Upgrade
Anavex Life Sciences Corp --
Phathom Pharmaceuticals Inc Upgrade

EV to Revenues Related Metrics

EV to Free Cash Flow Upgrade
EV to Assets (Quarterly) Upgrade